| Name | Thalidomide-Piperazine-PEG2-NH2 |
|---|---|
| Synonyms |
5-[4-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione
1H-Isoindole-1,3(2H)-dione, 5-[4-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl) 5-(4-{2-[2-(2-aminoethoxy)ethoxy]ethyl}piperazin-1-yl)-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione |
| Description | Thalidomide-Piperazine-PEG2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
|---|---|
| Related Catalog | |
| Target |
Cereblon |
| In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| References |
| Molecular Formula | C23H31N5O6 |
|---|---|
| Molecular Weight | 473.52 |